1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 5: 
Primary outcome in as-treated analysis
As-treated analysis 1-year outcomeaCA 
(n = 94)		SAC 
(n = 104)
Treatment failure (composite) (No.) (%)29 (30.9)27 (26.0)
 Clinical
  mRS 61 (1.1)4 (3.9)
  mRS 3–53 (3.2)3 (3.1)
  Intracranial hemorrhage00
  Retreatment03 (3.2)
 Angiographic
  Immediate failure3 (3.3)1 (1.1)
  Residual aneurysm (core lab)22 (25.3)16 (17.6)
 Missing primary outcome02 (1.9)
  • ↵a RR = 0.86; 95% CI, 0.55–1.34; P  = .498.